EcoR1 Capital LLC 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-05 1:03 pm Sale |
2021-09-30 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 81,077 0.200% |
-5,000,000 (-98.40%) |
Filing |
| 2021-09-23 3:14 pm Purchase |
2021-09-22 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 5,081,077 12.000% |
1,501,700 (+41.95%) |
Filing |
| 2021-05-11 4:06 pm Purchase |
2021-05-04 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
EcoR1 Capital LLC | 3,579,377 8.500% |
3,579,377 (New Position) |
Filing |